1,723,455 research outputs found
DevPsyLab/petersenlab: v0.1.2-9027
No full text<p><strong>Full Changelog</strong>: https://github.com/DevPsyLab/petersenlab/compare/v0.1.2-9026...v0.1.2-9027</p>
Union Pacific (UP) 9027
No full textA photograph print showing Union Pacific (UP) 9027, 4-12-2, Cheyenne, WY
Linked collectors and determiners for: Occurrence of invertebrates from all over Africa in natural history museum collection in Nairobi, Kenya.
No full textNatural history specimen data linked to collectors and determiners held within, "Occurrence of invertebrates from all over Africa in natural history museum collection in Nairobi, Kenya". Claims or attributions were made on Bionomia by volunteer Scribes, <a href="http://bionomia.net/dataset/3b8eb92e-2967-42a7-9027-2351e6956813">https://bionomia.net/dataset/3b8eb92e-2967-42a7-9027-2351e6956813</a> using specimen data from the dataset aggregated by the Global Biodiversity Information Facility, <a href="https://gbif.org/dataset/3b8eb92e-2967-42a7-9027-2351e6956813">https://gbif.org/dataset/3b8eb92e-2967-42a7-9027-2351e6956813</a>. Formatted as a Frictionless Data package
Linked collectors and determiners for: NEON Biorepository Zooplankton Collection (Remaining Bulk Taxonomy Sample).
No full textNatural history specimen data linked to collectors and determiners held within, "NEON Biorepository Zooplankton Collection (Remaining Bulk Taxonomy Sample)". Claims or attributions were made on Bionomia by volunteer Scribes, <a href="http://bionomia.net/dataset/60526e0c-6ef7-4610-9027-e604d448b959">https://bionomia.net/dataset/60526e0c-6ef7-4610-9027-e604d448b959</a> using specimen data from the dataset aggregated by the Global Biodiversity Information Facility, <a href="https://gbif.org/dataset/60526e0c-6ef7-4610-9027-e604d448b959">https://gbif.org/dataset/60526e0c-6ef7-4610-9027-e604d448b959</a>. Formatted as a Frictionless Data package
Long-term effects of the Galactic tide on cometary dynamics
No full textCelestial Mechanics and Dynamical Astronomy, 95, pp. 299-326, http://dx.doi.org./10.1007/s10569-006-9027-8International audienc
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Recombinant FVIIIFc Versus BAY 94-9027 for Treatment of Patients with Haemophilia A:Comparative Efficacy Using a Matching Adjusted Indirect Comparison
Full text linkINTRODUCTION: Prophylaxis with recombinant factor VIII (rFVIII) is the current standard of care for haemophilia A. Several approaches have been used to extend the half-life of rFVIII to improve prophylaxis outcomes. An indirect comparison of pivotal clinical trial data was performed to evaluate the relative efficacy of two extended half-life therapies approved for the prophylactic treatment of haemophilia A: recombinant FVIII-IgG1 Fc domain fusion protein (rFVIIIFc) and pegylated rFVIII (BAY 94-9027).METHODS: Matching-adjusted indirect comparison (MAIC) was conducted to compare the rFVIIIFc individualised prophylaxis arm of the A-LONG phase III clinical trial (n = 117) and the BAY 94-9027 approved dosing regimens of the PROTECT VIII phase II/III study (n = 110). Following matching for baseline characteristics, mean annualised bleeding rate (ABR) and the proportion of patients with zero bleeds were compared for rFVIIIFc and BAY 94-9027. Additional supportive analyses comparing rFVIIIFc individualised prophylaxis and the individual prophylaxis regimens included in the PROTECT VIII group (twice weekly, and every 5 and 7 days [Q5D and Q7D]) were conducted.RESULTS: Mean ABR was lower in the rFVIIIFc individualised prophylaxis group versus the BAY 94-9027 pooled prophylaxis population (3.0 versus 4.9), providing a clinically relevant and statistically significant difference (mean difference [MD] - 1.9; 95% confidence interval [CI] - 3.5 to - 0.4). A statistically significant difference in ABR was also observed for rFVIIIFc compared with BAY 94-9027 Q7D (3.2 versus 6.4; MD - 3.3; 95% CI - 6.4 to - 0.2). The difference in the proportion of patients with zero bleeds between rFVIIIFc (46.5%) and BAY 94-9027 pooled prophylaxis population (38.2%) was not statistically significant (odds ratio 1.4; 95% CI 0.8 to 2.5).CONCLUSIONS: This indirect treatment comparison indicates a statistically significant and clinically relevant difference in ABR favouring individualised prophylaxis with rFVIIIFc versus BAY 94-9027 prophylaxis. The proportion of patients with zero bleeds was numerically greater with rFVIIIFc treatment but did not achieve statistical significance.</p
- …
